+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Radiopharmaceuticals Market Research Report by Type, by Procedural Volume, by Application - United States Forecast to 2025 - Cumulative Impact of COVID-19

  • ID: 5123983
  • Report
  • July 2020
  • Region: United States
  • 95 pages
  • 360iResearch™
UP TO OFF
until Dec 31st 2020
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Bayer AG
  • Cardinal Health, Inc.
  • Curium France SASU
  • GE Healthcare Inc
  • MORE
The United States Radiopharmaceuticals Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Radiopharmaceuticals Market.

Market Segmentation & Coverage:

This research report categorizes the Radiopharmaceuticals market to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Radiopharmaceuticals Market studied across Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine. The Diagnostic Nuclear Medicine further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Therapeutic Nuclear Medicine further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes.

Based on Procedural Volume, the Radiopharmaceuticals Market studied across Diagnostic Procedures and Therapeutic Procedures. The Diagnostic Procedures further studied across Pet Radiopharmaceuticals and Spect Radiopharmaceuticals. The Therapeutic Procedures further studied across Alpha Emitters, Beta Emitters, and Brachytherapy Isotopes.

Based on Application, the Radiopharmaceuticals Market studied across Diagnostic Applications and Therapeutic Applications. The Diagnostic Applications further studied across Pet Applications and Spect Applications. The Therapeutic Applications further studied across Bone Metastasis, Endocrine Tumors, Lymphoma, and Thyroid.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the United States Radiopharmaceuticals Market including Bayer AG, Cardinal Health, Inc., Curium France SASU, GE Healthcare Inc, and Lantheus Medical Imaging, Inc..

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Radiopharmaceuticals Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Radiopharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Radiopharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Radiopharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the United States Radiopharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the United States Radiopharmaceuticals Market?
6. What are the modes and strategic moves considered suitable for entering the United States Radiopharmaceuticals Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bayer AG
  • Cardinal Health, Inc.
  • Curium France SASU
  • GE Healthcare Inc
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome

3. Executive Summary
3.1. Market Outlook
3.2. Type Outlook
3.3. Procedural Volume Outlook
3.4. Application Outlook
3.5. Competitor Outlook

4. Market Overview
4.1. Introduction

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. United States Radiopharmaceuticals Market, By Type
6.1. Introduction
6.2. Diagnostic Nuclear Medicine
6.2.1. Pet Radiopharmaceuticals
6.2.1.1. F-18
6.2.1.2. Ru-82
6.2.2. Spect Radiopharmaceuticals
6.2.2.1. Ga-67
6.2.2.2. I-123
6.2.2.3. Tc-99m
6.2.2.4. Tl-201
6.3. Therapeutic Nuclear Medicine
6.3.1. Alpha Emitters
6.3.1.1. Ra-223
6.3.2. Beta Emitters
6.3.2.1. I-131
6.3.2.2. Lu-177
6.3.2.3. Re-186
6.3.2.4. Sm-153
6.3.2.5. Y-90
6.3.3. Brachytherapy Isotopes
6.3.3.1. Cs-131
6.3.3.2. I-125
6.3.3.3. Ir-192
6.3.3.4. Pd-103

7. United States Radiopharmaceuticals Market, By Procedural Volume
7.1. Introduction
7.2. Diagnostic Procedures
7.2.1. Pet Radiopharmaceuticals
7.2.2. Spect Radiopharmaceuticals
7.3. Therapeutic Procedures
7.3.1. Alpha Emitters
7.3.2. Beta Emitters
7.3.3. Brachytherapy Isotopes

8. United States Radiopharmaceuticals Market, By Application
8.1. Introduction
8.2. Diagnostic Applications
8.2.1. Pet Applications
8.2.1.1. Cardiology
8.2.1.2. Neurology
8.2.1.3. Oncology
8.2.2. Spect Applications
8.2.2.1. Cardiology
8.2.2.2. Lymphoma
8.2.2.3. Neurology
8.2.2.4. Thyroid
8.3. Therapeutic Applications
8.3.1. Bone Metastasis
8.3.2. Endocrine Tumors
8.3.3. Lymphoma
8.3.4. Thyroid

9. Competitive Strategic Window
9.1. Introduction
9.2. Competitive Strategic Window, by Type
9.3. Competitive Strategic Window, by Procedural Volume
9.4. Competitive Strategic Window, by Application

10. Competitive Landscape
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitive Scenario
10.4.1. Merger & Acquisition
10.4.2. Agreement, Collaboration, & Partnership
10.4.3. New Product Launch & Enhancement
10.4.4. Investment & Funding
10.4.5. Award, Recognition, & Expansion

11. Company Usability Profiles
11.1. Bayer AG
11.2. Cardinal Health, Inc.
11.3. Curium France SASU
11.4. GE Healthcare Inc
11.5. Lantheus Medical Imaging, Inc.

12. Appendix
12.1. Discussion Guide
12.2. Edition Details
12.3. License Details
12.4. Pricing Details

LIST OF FIGURES
FIGURE 1. UNITED STATES RADIOPHARMACEUTICALS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES RADIOPHARMACEUTICALS MARKET: RESEARCH EXECUTION
FIGURE 3. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, 2019 VS 2025 (USD MILLION)
FIGURE 4. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019 VS 2025 (USD MILLION)
FIGURE 5. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019 VS 2025 (USD MILLION)
FIGURE 6. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 7. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES RADIOPHARMACEUTICALS MARKET, BY TYPE
FIGURE 8. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, 2017-2025 (USD MILLION)
FIGURE 9. UNITED STATES RADIOPHARMACEUTICALS MARKET: MARKET DYNAMICS
FIGURE 10. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2019 VS 2025 (USD MILLION)
FIGURE 11. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2019 VS 2025 (USD MILLION)
FIGURE 12. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019 VS 2025 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PROCEDURAL VOLUME, 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2025 (USD MILLION)
FIGURE 16. UNITED STATES RADIOPHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX
FIGURE 17. UNITED STATES RADIOPHARMACEUTICALS MARKET: MARKET SHARE ANALYSIS

LIST OF TABLES
TABLE 1. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, 2017-2025 (USD MILLION)
TABLE 2. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC NUCLEAR MEDICINE, 2017-2025 (USD MILLION)
TABLE 3. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2017-2025 (USD MILLION)
TABLE 4. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY F-18, 2017-2025 (USD MILLION)
TABLE 5. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RU-82, 2017-2025 (USD MILLION)
TABLE 6. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2017-2025 (USD MILLION)
TABLE 7. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY GA-67, 2017-2025 (USD MILLION)
TABLE 8. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-123, 2017-2025 (USD MILLION)
TABLE 9. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TC-99M, 2017-2025 (USD MILLION)
TABLE 10. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY TL-201, 2017-2025 (USD MILLION)
TABLE 11. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC NUCLEAR MEDICINE, 2017-2025 (USD MILLION)
TABLE 12. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2017-2025 (USD MILLION)
TABLE 13. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RA-223, 2017-2025 (USD MILLION)
TABLE 14. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2017-2025 (USD MILLION)
TABLE 15. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-131, 2017-2025 (USD MILLION)
TABLE 16. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LU-177, 2017-2025 (USD MILLION)
TABLE 17. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RE-186, 2017-2025 (USD MILLION)
TABLE 18. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SM-153, 2017-2025 (USD MILLION)
TABLE 19. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY Y-90, 2017-2025 (USD MILLION)
TABLE 20. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2017-2025 (USD MILLION)
TABLE 21. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CS-131, 2017-2025 (USD MILLION)
TABLE 22. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY I-125, 2017-2025 (USD MILLION)
TABLE 23. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY IR-192, 2017-2025 (USD MILLION)
TABLE 24. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PD-103, 2017-2025 (USD MILLION)
TABLE 25. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2025 (USD MILLION)
TABLE 26. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET RADIOPHARMACEUTICALS, 2017-2025 (USD MILLION)
TABLE 27. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT RADIOPHARMACEUTICALS, 2017-2025 (USD MILLION)
TABLE 28. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2017-2025 (USD MILLION)
TABLE 29. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ALPHA EMITTERS, 2017-2025 (USD MILLION)
TABLE 30. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BETA EMITTERS, 2017-2025 (USD MILLION)
TABLE 31. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BRACHYTHERAPY ISOTOPES, 2017-2025 (USD MILLION)
TABLE 32. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC APPLICATIONS, 2017-2025 (USD MILLION)
TABLE 33. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PET APPLICATIONS, 2017-2025 (USD MILLION)
TABLE 34. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2017-2025 (USD MILLION)
TABLE 35. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2017-2025 (USD MILLION)
TABLE 36. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, 2017-2025 (USD MILLION)
TABLE 37. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY SPECT APPLICATIONS, 2017-2025 (USD MILLION)
TABLE 38. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, 2017-2025 (USD MILLION)
TABLE 39. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2017-2025 (USD MILLION)
TABLE 40. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, 2017-2025 (USD MILLION)
TABLE 41. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2017-2025 (USD MILLION)
TABLE 42. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC APPLICATIONS, 2017-2025 (USD MILLION)
TABLE 43. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY BONE METASTASIS, 2017-2025 (USD MILLION)
TABLE 44. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINE TUMORS, 2017-2025 (USD MILLION)
TABLE 45. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY LYMPHOMA, 2017-2025 (USD MILLION)
TABLE 46. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY THYROID, 2017-2025 (USD MILLION)
TABLE 47. UNITED STATES RADIOPHARMACEUTICALS MARKET: SCORES
TABLE 48. UNITED STATES RADIOPHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 49. UNITED STATES RADIOPHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 50. UNITED STATES RADIOPHARMACEUTICALS MARKET: RANKING
TABLE 51. UNITED STATES RADIOPHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 52. UNITED STATES RADIOPHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 53. UNITED STATES RADIOPHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 54. UNITED STATES RADIOPHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 55. UNITED STATES RADIOPHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 56. UNITED STATES RADIOPHARMACEUTICALS MARKET: EDITION DETAILS
TABLE 57. UNITED STATES RADIOPHARMACEUTICALS MARKET: LICENSE DETAILS
TABLE 58. UNITED STATES RADIOPHARMACEUTICALS MARKET: PRICING DETAILS
Note: Product cover images may vary from those shown
3 of 3
  • Bayer AG
  • Cardinal Health, Inc.
  • Curium France SASU
  • GE Healthcare Inc
  • Lantheus Medical Imaging, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll